{
  "id": "601cb5be1cb411341a000025",
  "type": "factoid",
  "question": "Inhaled Molgramostim can be used for treatment of which disease?",
  "ideal_answer": "Inhaled Molgramostim was shown to be effective for Autoimmune Pulmonary Alveolar Proteinosis.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29719809",
    "http://www.ncbi.nlm.nih.gov/pubmed/32897035"
  ],
  "snippets": [
    {
      "text": "Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32897035",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "METHODS: In a double-blind, placebo-controlled, three-group trial, we randomly assigned patients with aPAP to receive the recombinant GM-CSF molgramostim (300 \u03bcg once daily by inhalation), either continuously or intermittently (every other week), or matching placebo.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32897035",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS: In patients with aPAP, daily administration of inhaled molgramostim resulted in greater improvements in pulmonary gas transfer and functional health status than placebo, with similar rates of adverse events. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32897035",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29719809",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We here describe a unique case of a 14-year-old patient who was successfully treated with WLL and subsequent inhalations with molgramostim - new recombinant human GM-CSF (rhGM-CSF).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29719809",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32897035",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29719809",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "Autoimmune Pulmonary Alveolar Proteinosis"
}